Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.
Although the probiotic Escherichia coli strain Nissle 1917 has been proven to be efficacious for the treatment of inflammatory bowel diseases, the underlying mechanisms of action still remain elusive. The aim of the present study was to analyze the effects of E. coli Nissle 1917 on cell cycling and apoptosis of peripheral blood and lamina propria T cells (PBT and LPT, respectively). Anti-CD3-stimulated PBT and LPT were treated with E. coli Nissle 1917-conditioned medium (E. coli Nissle 1917-CM) or heat-inactivated E. coli Nissle 1917. Cyclin B1, DNA content, and caspase 3 expression were measured by flow cytometry to assess cell cycle kinetics and apoptosis. Protein levels of several cell cycle and apoptosis modulators were determined by immunoblotting, and cytokine profiles were determined by cytometric bead array. E. coli Nissle 1917-CM inhibits cell cycling and expansion of peripheral blood but not mucosal T cells. Bacterial lipoproteins mimicked the effect of E. coli Nissle 1917-CM; in contrast, heat-inactivated E. coli Nissle 1917, lipopolysaccharide, or CpG DNA did not alter PBT cell cycling. E. coli Nissle 1917-CM decreased cyclin D2, B1, and retinoblastoma protein expression, contributing to the reduction of T-cell proliferation. E. coli Nissle 1917 significantly inhibited the expression of interleukin-2 (IL-2), tumor necrosis factor alpha, and gamma interferon but increased IL-10 production in PBT. Using Toll-like receptor 2 (TLR-2) knockout mice, we further demonstrate that the inhibition of PBT proliferation by E. coli Nissle 1917-CM is TLR-2 dependent. The differential reaction of circulating and tissue-bound T cells towards E. coli Nissle 1917 may explain the beneficial effect of E. coli Nissle 1917 in intestinal inflammation. E. coli Nissle 1917 may downregulate the expansion of newly recruited T cells into the mucosa and limit intestinal inflammation, while already activated tissue-bound T cells may eliminate deleterious antigens in order to maintain immunological homeostasis.
Sturm
Andreas
A
Department of Hepatology and Gastroenterology, Campus Virchow Clinic, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany. andreas.sturm@charite.de
Rilling
Klaus
K
Baumgart
Daniel C
DC
Gargas
Konstantinos
K
Abou-Ghazalé
Tay
T
Raupach
Bärbel
B
Eckert
Jana
J
Schumann
Ralf R
RR
Enders
Corinne
C
Sonnenborn
Ulrich
U
Wiedenmann
Bertram
B
Dignass
Axel U
AU
D017209:Apoptosis; D002453:Cell Cycle; D002455:Cell Division; D004926:Escherichia coli / Q000276:immunology*; D005786:Gene Expression Regulation; D006801:Humans; D007413:Intestinal Mucosa / Q000166:cytology / Q000276:immunology; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology; D008562:Membrane Glycoproteins / Q000378:metabolism*; D019936:Probiotics; D011956:Receptors, Cell Surface / Q000378:metabolism*; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000166:cytology* / Q000276:immunology*; D051195:Toll-Like Receptor 2; D051193:Toll-Like Receptors
D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface; C495342:TLR2 protein, human; D051195:Toll-Like Receptor 2; D051193:Toll-Like Receptors
Gastroenterology. 1998 Dec;115(6):1405-13
9834268
Cell. 1999 Jan 22;96(2):245-54
9988219
Annu Rev Immunol. 1999;17:221-53
10358758
Gastroenterol Clin North Am. 1999 Jun;28(2):323-51
10372271
FEMS Immunol Med Microbiol. 1999 Nov;26(2):131-5
10536299
Immunity. 1999 Oct;11(4):443-51
10549626
Nat Cell Biol. 1999 Sep;1(5):E131-8
10559956
Science. 2000 Aug 25;289(5483):1311-2
10979858
Aliment Pharmacol Ther. 1997 Dec;11 Suppl 3:81-5; discussion 85-8
9467982
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5045-50
9560225
Cytometry. 1998 Jun 1;32(2):71-7
9627219
Genes Dev. 1999 Jun 15;13(12):1501-12
10385618
Science. 1999 Jul 30;285(5428):736-9
10426996
J Immunol. 1999 Aug 15;163(4):1742-5
10438903
Lancet. 1999 Aug 21;354(9179):635-9
10466665
Gastroenterology. 1999 Oct;117(4):761-9
10500056
Am J Gastroenterol. 2000 Jan;95(1 Suppl):S19-21
10634224
Immunol Cell Biol. 2000 Feb;78(1):55-66
10651930
J Immunol. 2000 Jul 15;165(2):931-40
10878368
Gastroenterology. 2000 Aug;119(2):305-9
10930365
Cytometry. 2000 Sep 1;41(1):1-8
10942890
Immunol Today. 2000 Nov;21(11):551-5
11094258
N Engl J Med. 2001 Mar 1;344(9):655-64
11228281
Gastroenterology. 2001 Feb;120(3):622-35
11179240
Gut. 2001 Mar;48(3):320-5
11171820
Gut. 2001 May;48(5):609
11302956
Nature. 2001 Jun 14;411(6839):820-4
11459064
Infect Immun. 2001 Sep;69(9):5529-37
11500426
N Engl J Med. 2001 Oct 11;345(15):1098-104
11596589
Gastroenterology. 2001 Nov;121(5):1145-57
11677207
Am J Gastroenterol. 2001 Nov;96(11):3218-9
11721788
Scand J Gastroenterol Suppl. 2001;(234):29-40
11768558
Gastroenterology. 2002 Jan;122(1):44-54
11781279
Gut. 2002 Feb;50(2):206-11
11788561
Annu Rev Immunol. 2002;20:709-60
11861616
J Rheumatol. 2002 Apr;29(4):647-9
11950000
Mol Immunol. 2002 May;38(14):1051-61
11955597
J Immunol. 2002 May 1;168(9):4531-7
11970999
Gastroenterology. 2002 May;122(5):1334-45
11984520
BioDrugs. 2002;16(2):111-48
11985485
J Clin Invest. 2002 Jun;109(11):1481-92
12045262
Aliment Pharmacol Ther. 2002 Aug;16(8):1383-93
12182739
Immunol Rev. 2002 Jul;185:86-102
12190925
Curr Opin Cell Biol. 2002 Dec;14(6):684-91
12473340
J Biol Chem. 2002 Dec 27;277(52):50959-65
12393915
J Immunol. 2003 Jan 1;170(1):194-200
12496400
Crit Rev Immunol. 2002;22(3):217-50
12498384
Nat Rev Cancer. 2003 Feb;3(2):130-8
12563312
Science. 2003 Feb 14;299(5609):1033-6
12532024
J Exp Med. 2003 Feb 17;197(4):403-11
12591899
Annu Rev Immunol. 2003;21:305-34
12471050
Scand J Gastroenterol. 2003 Feb;38(2):172-9
12678334
Gastroenterology. 2003 May;124(5):1202-9
12730861
FEBS Lett. 2003 Jun 5;544(1-3):4-10
12782281
Inflamm Bowel Dis. 2003 May;9(3):210-1
12797349
Clin Exp Immunol. 2003 Oct;134(1):127-37
12974765
Gut. 2004 Jan;53(1):108-14
14684584
Gastroenterology. 2004 Feb;126(2):520-8
14762789
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3029-34
14981245
Clin Diagn Lab Immunol. 2004 Mar;11(2):372-8
15013990
J Immunol. 2004 Apr 1;172(7):4463-9
15034062
Cytometry. 1985 Nov;6(6):620-6
4064842
J Immunol. 1992 Oct 15;149(8):2816-22
1383328
Lancet. 1994 Oct 22;344(8930):1105-10
7934491
Cell. 1994 Nov 18;79(4):551-5
7954821
Cell. 1995 May 5;81(3):323-30
7736585
J Cell Biochem. 1995 Jun;58(2):175-80
7673325
Gastroenterology. 1995 Oct;109(4):1029-38
7557067
Immunol Today. 1995 Jul;16(7):322-4
7576064
Clin Exp Immunol. 1995 Dec;102(3):448-55
8536356
Eur J Immunol. 1996 Apr;26(4):934-8
8625991
Semin Immunol. 1997 Feb;9(1):1-5
9106302
Immunol Rev. 1997 Apr;156:145-66
9176706
N Engl J Med. 1997 Oct 9;337(15):1029-35
9321530
Aliment Pharmacol Ther. 1997 Oct;11(5):853-8
9354192
Digestion. 1997;58(5):469-75
9383639
Gastroenterology. 1998 Jul;115(1):182-205
9649475